Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors

Lung cancer is the leading cause of cancer death worldwide, with approximately 1.6 million cancer related deaths each year. Prognosis is best in patients with early stage disease, though even then five-year survival is only 55% in some groups. Median survival for advanced non-small cell lung cancer...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Transl Lung Cancer Res
Päätekijät: Rangamuwa, Kanishka, Leong, Tracy, Weeden, Clare, Asselin-Labat, Marie-Liesse, Bozinovski, Steven, Christie, Michael, John, Tom, Antippa, Phillip, Irving, Louis, Steinfort, Daniel
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: AME Publishing Company 2021
Aiheet:
Review Article on Lung Cancer and The Immune System
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8264311/
https://ncbi.nlm.nih.gov/pubmed/34295682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-1075
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia